Cargando…
Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
The global tuberculosis (TB) epidemic caused by the bacterial pathogen Mycobacterium tuberculosis (M.tb) continues unabated. The Mycobacterium bovis bacillus Calmette–Guérin (BCG) vaccination is widely utilized worldwide to protect against infection with M.tb. BCG vaccine protection against TB has h...
Autores principales: | Verma, Deepshikha, Chan, Edward D., Ordway, Diane J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711602/ https://www.ncbi.nlm.nih.gov/pubmed/33207695 http://dx.doi.org/10.3390/vaccines8040688 |
Ejemplares similares
-
Characterization of Immune Cells From the Lungs of Patients With Chronic Non-Tuberculous Mycobacteria or Pseudomonas aeruginosa Infection
por: Schenkel, Alan R., et al.
Publicado: (2022) -
Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014) -
Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?
por: Warner, Sherridan, et al.
Publicado: (2023) -
Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
por: Faverio, Paola, et al.
Publicado: (2016) -
Methods of phenotypic identification of non-tuberculous mycobacteria
por: Bhalla, Gurpreet S., et al.
Publicado: (2018)